These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 22291709)
1. The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model. Piper C; Casey PG; Hill C; Cotter PD; Ross RP Int J Microbiol; 2012; 2012():806230. PubMed ID: 22291709 [TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial effect and in vivo preventive and therapeutic effects of partially purified lantibiotic lacticin NK34 against infection by Staphylococcus species isolated from bovine mastitis. Kim SY; Shin S; Koo HC; Youn JH; Paik HD; Park YH J Dairy Sci; 2010 Aug; 93(8):3610-5. PubMed ID: 20655430 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Nisin F in the Treatment of Subcutaneous Skin Infections, as Monitored by Using a Bioluminescent Strain of Staphylococcus aureus. de Kwaadsteniet M; van Reenen CA; Dicks LM Probiotics Antimicrob Proteins; 2010 Jun; 2(2):61-5. PubMed ID: 26781114 [TBL] [Abstract][Full Text] [Related]
4. Development of a Murine Model with Optimal Routes for Bacterial Infection and Treatment, as Determined with Bioluminescent Imaging in C57BL/6 Mice. Brand AM; Smith R; de Kwaadsteniet M; Dicks LM Probiotics Antimicrob Proteins; 2011 Jun; 3(2):125-31. PubMed ID: 26781578 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria. Iancu C; Grainger A; Field D; Cotter PD; Hill C; Ross RP Probiotics Antimicrob Proteins; 2012 Jun; 4(2):108-15. PubMed ID: 26781852 [TBL] [Abstract][Full Text] [Related]
6. The novel antibacterial drug XF-70 is a potent inhibitor of Staphylococcus aureus infection of the burn wound. Hurtuk MG; He LK; Szilagyi A; Gamelli RL; Hecht DW; Kennedy RH; Rhys-Williams W; Love WG; Shankar R J Burn Care Res; 2010; 31(3):462-9. PubMed ID: 20453736 [TBL] [Abstract][Full Text] [Related]
7. The Effects of Continuous In Vivo Administration of Nisin on Staphylococcus aureus Infection and Immune Response in Mice. Brand AM; Smith C; Dicks LM Probiotics Antimicrob Proteins; 2013 Dec; 5(4):279-86. PubMed ID: 26783073 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging. van Staden Adu P; Heunis T; Smith C; Deane S; Dicks LM Antimicrob Agents Chemother; 2016 Jul; 60(7):3948-55. PubMed ID: 27067340 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. Piper C; Draper LA; Cotter PD; Ross RP; Hill C J Antimicrob Chemother; 2009 Sep; 64(3):546-51. PubMed ID: 19561147 [TBL] [Abstract][Full Text] [Related]
10. The lantibiotic lacticin 3147 produced in a milk-based medium improves the efficacy of a bismuth-based teat seal in cattle deliberately infected with Staphylococcus aureus. Crispie F; Twomey D; Flynn J; Hill C; Ross P; Meaney W J Dairy Res; 2005 May; 72(2):159-67. PubMed ID: 15909681 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis. Klostermann K; Crispie F; Flynn J; Meaney WJ; Paul Ross R; Hill C J Dairy Res; 2010 May; 77(2):231-8. PubMed ID: 19785910 [TBL] [Abstract][Full Text] [Related]
12. Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147. Twomey DP; Wheelock AI; Flynn J; Meaney WJ; Hill C; Ross RP J Dairy Sci; 2000 Sep; 83(9):1981-8. PubMed ID: 11003227 [TBL] [Abstract][Full Text] [Related]
13. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Draper LA; Grainger K; Deegan LH; Cotter PD; Hill C; Ross RP Mol Microbiol; 2009 Feb; 71(4):1043-54. PubMed ID: 19183281 [TBL] [Abstract][Full Text] [Related]
14. Monitoring of abdominal Staphylococcus aureus infection using magnetic resonance imaging: a murine animal model for hepatic and renal abscesses. Kromrey ML; Göhler A; Friedrich N; Kindermann K; Hadlich S; Puls D; Steinmetz I; Kühn JP Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):373-378. PubMed ID: 27778120 [TBL] [Abstract][Full Text] [Related]
15. In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains. Frosco MB; Melton JL; Stewart FP; Kulwich BA; Licata L; Barrett JF Antimicrob Agents Chemother; 1996 Nov; 40(11):2529-34. PubMed ID: 8913458 [TBL] [Abstract][Full Text] [Related]
16. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Fattom AI; Sarwar J; Ortiz A; Naso R Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375 [TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model. Lepak AJ; Marchillo K; Craig WA; Andes DR Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404 [TBL] [Abstract][Full Text] [Related]
18. Purification and Partial Characterization of Lacticin 481, a Lanthionine-Containing Bacteriocin Produced by Lactococcus lactis subsp. lactis CNRZ 481. Piard JC; Muriana PM; Desmazeaud MJ; Klaenhammer TR Appl Environ Microbiol; 1992 Jan; 58(1):279-84. PubMed ID: 16348628 [TBL] [Abstract][Full Text] [Related]
19. A Polysaccharide isolated from the liquid culture of Lentinus edodes (Shiitake) mushroom mycelia containing black rice bran protects mice against salmonellosis through upregulation of the Th1 immune reaction. Kim SP; Park SO; Lee SJ; Nam SH; Friedman M J Agric Food Chem; 2014 Mar; 62(11):2384-91. PubMed ID: 24593132 [TBL] [Abstract][Full Text] [Related]
20. Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Navaratna MA; Sahl HG; Tagg JR Infect Immun; 1999 Aug; 67(8):4268-71. PubMed ID: 10417203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]